History of Teva US Generics
Pictured is the first Teva building, a wholesale drug business is founded in Jerusalem in 1901. The Teva organization's rich history dates back to 1901 when the company was founded in Israel as a small business distributing imported medications. By 1945, operations in the United States were formed as Lemmon Pharmacal Company, which was acquired by Teva in the 1980s. More recently, the company, renamed Teva Pharmaceuticals USA, became a wholly owned subsidiary of Israeli-based Teva Pharmaceuticals Industries Ltd., the world leader in generic pharmaceutical products.1
Below is a timeline marking the events that solidified Teva's lead position in the United States' generic pharmaceutical industry and furthered our mission to make better healthcare accessible.
| 2008 | On December 23, 2008, Barr Pharmaceuticals, Inc. was acquired by Teva Pharmaceutical Industries Ltd., establishing a stronger, more competitive company with increased scale and an expanded geographic footprint with significant potential for growth. Read additional information. |
| 2006 | On January 26, 2006, Ivax Corporation was acquired by Teva Pharmaceutical Industries Ltd., creating one of the most dynamic companies in the pharmaceutical industry. Read additional information. |
| 2004 | On January 22, 2004, Sicor became a wholly-owned subsidiary of Teva. This acquisition brings together two premier generic pharmaceutical companies, combining Teva's successful oral dose generic drugs franchise with Sicor's leading generic injectable business. In addition, both the Active Pharmaceutical Ingredients (API) businesses and Sicor's biogenerics capabilities will enhance and expand the combined company's product offerings. (Note: "Sicor" was renamed "Teva Parenteral Medicines, Inc." in 2007.) |
| 2003 | Teva Pharmaceutical Industries Ltd. enters into a strategic collaboration with Andrx Corporation to develop and market generic oral contraceptive pharmaceutical products. |
| 2003 | Teva enters into an exclusivity transfer agreement with Andrx Corporation and Impax Laboratories, Inc. pertaining to the pending ANDAs for bioequivalent versions of Wellbutrin® SR and Zyban® (Bupropion Hydrochloride) 100 mg and 150 mg Extended Release Tablets. |
| 2001 | Teva Pharmaceutical Industries Ltd. enters into a strategic alliance agreement with Impax Laboratories, Inc. for controlled release generic pharmaceutical products. |
| 2000 | Teva Pharmaceutical Industries Ltd. acquires Novopharm Ltd., Canada's second largest generic drug company with operations in the United States and Hungary. |
| 1999 | Teva Pharmaceutical Industries Ltd. acquires Copley Pharmaceutical, Inc. |
| 1999 | Teva Pharmaceutical Industries Ltd. enters into a strategic alliance with Bio-Technology General Corp. for the development and global commercialization of generic recombinant therapeutic products. |
| 1996 | Lemmon Company merges with Biocraft Laboratories and changes its name to Teva Pharmaceuticals USA (Teva USA). |
1 Internal Information Including information from: http://www.tevapharm.com/en-US/About/CompanyProfile/Pages/WhoWeAre.aspx
